|
|
Rapid Micro Biosystems Inc (RPID) |
|
|
|
Rapid Micro Biosystems Inc 's Yearly Income from Continued Operations Growth 5 Years |
|
Select the Comparisons :
|
|
Select the Ratio:
|
Annual Income from Cont. Operations Annual Growth Rates Y/Y▼
|
Annual Income from Cont. Operations Annual Growth Rates Y/Y▼
|
RPID Annual Income from Cont. Operations Growth |
2022
|
2021
|
|
|
|
Y / Y Annual Income from Cont. Operations Change |
- |
- |
- |
- |
- |
Annual Income from Cont. Operations (in millions $) |
$0.58 |
$-73.52 |
$0.00 |
$0.00 |
$0.00 |
Annual Income from Cont. Operations Growth
Comment |
In the fiscal year ended 2022, company achieved Annual Income from Cont. Operations of $0.58 millions compare to loss from Cont. Operations of $-73.52 millions realized a year before.
Rapid Micro Biosystems Inc Annual Income Statement
|
You need to upgrade your Flash Player
|
Companies with similar 2022 Annual Income from Cont. Operations within Healthcare Sector | Y/Y Income from Continued Operations Growth % | 2022 Annual Income from Cont. Operations | Ligand Pharmaceuticals Incorporated | | | |